Infections and Chronic Inflammatory Bowel Disease

Area of Science:

• Gastroenterology and Immunology
• Infectious Diseases
• Clinical Therapeutics

Background:

• The advent of anti-TNF therapy has shifted inflammatory bowel disease (IBD) treatment towards early intensive immunosuppression.
• While effective, this intensified approach elevates the risk of serious side effects, particularly infectious complications.
• Diagnosing infections in immunocompromised IBD patients is challenging due to diverse pathogens and atypical presentations.

Purpose of the Study:

• To provide a comprehensive overview of infectious complications in IBD patients undergoing intensified immunosuppression.
• To outline diagnostic and therapeutic strategies for both pulmonary and intestinal infections.
• To emphasize the importance of early detection and management of infections in this vulnerable population.

Main Methods:

• Literature review and synthesis of current treatment strategies for IBD.
• Discussion of infectious agents and their clinical manifestations in immunocompromised patients.
• Presentation of diagnostic algorithms and therapeutic recommendations for pulmonary and intestinal infections.

Main Results:

• Intensified immunosuppression, while beneficial for IBD control, significantly increases susceptibility to infections.
• Pulmonary infections serve as a key example, with specific algorithms proposed for detection and treatment.
• Common intestinal infections are detailed, covering diagnosis through to therapeutic interventions.

Conclusions:

• Effective management of IBD with intensified immunosuppression necessitates vigilant monitoring for infectious complications.
• Structured approaches to diagnosing and treating pulmonary and intestinal infections are vital for patient safety.
• Balancing therapeutic efficacy with the risk of infection is paramount in modern IBD management.